Leiomyosarcoma with partial rhabdomyoblastic differentiation: First case report of primary cardiac origin by Okubo, Yoichiro et al.
CASE REPORT Open Access
Leiomyosarcoma with partial rhabdomyoblastic
differentiation: First case report of primary
cardiac origin
Yoichiro Okubo
1, Kazutoshi Shibuya
1, Atsushi Namiki
2, Kazuhisa Takamura
2*, Noriaki Kameda
1, Tetsuo Nemoto
1,
Aki Mitsuda
1, Megumi Wakayama
1, Minoru Shinozaki
1, Nobuyuki Hiruta
1, Kanako Kitahara
1, Takao Ishiwatari
1,
Junichi Yamazaki
2
Abstract
Background: Leiomyosarcoma occurring as a primary cardiac tumor has been known as an extremely rare
condition. Previous studies of leiomyosarcoma with rhabdomyoblastic differentiation have conducted to those
arisen from another site, and they indicated a poorer prognosis of this tumor.
Case presentation: A 69-year-old woman was referred to our hospital for an operation concerning umbilical
hernia. Subsequent imaging examinations before an operation indicated the presence of primary cardiac malignant
tumor due to its atypical shape. And then, it was surgically removed. Histopathologically, tumor cells consisted of
two different types: spindle and polyhedral cells. Immunohistochemically, it is interesting to note that 2.1% of
spindle cells and 23.1% of polyhedral cells showed positive reactivity for myogenin. Furthermore, we performed
double-immunostaining for alpha-smooth muscle actin (SMA) and myogenin. The rates of alpha-SMA and
myogenin double negative, alpha-SMA single positive, myogenin single positive, and alpha-SMA and myogenin
double positive in spindle cells were estimated as 69.1%, 28.8%, 1.1% and 1.0%, respectively. In contrast, the rates
in polyhedral cells were estimated as 76.9%, 0.0%, 23.1%, and 0.0%, respectively.
Conclusion: Our immunohistochemical evaluation suggested that rhabdomyoblastic differentiation in
leiomyosarcoma might be generated not only by de novo generation from mesenchymal cells. To the best of our
knowledge, this is the first case of primary cardiac leiomyosarcoma with partial rhabdomyoblastic differentiation.
Background
Primary cardiac tumors represent a rare neoplastic condi-
tion with an incidence that ranges from 0.0017 to 0.019%
[1], of which 25% are malignant. Among such tumors,
angiosarcoma is the commonest malignant tumor fol-
lowed by rhabdomyosarcoma, malignant mesothelioma,
and fibrosarcoma, each with an incidence that is greater
than 10% [2]. However, the incidence of cardiac leiomyo-
sarcoma is less than 1% [2]. Previous studies of leiomyo-
sarcoma with rhabdomyoblastic differentiation have
conducted to those arisen from another site [3-11], and
they announced a poorer prognosis of this tumor.
Especially, Oshiro et al. have reported that leiomyosar-
coma with rhabdomyoblastic differentiation shows poorer
prognosis than typical leiomyosarcoma [6]. In the present
paper, we describe an extremely rare primary cardiac
malignant tumor. To the best of our knowledge, this is the
first case of primary cardiac leiomyosarcoma with partial
rhabdomyoblastic differentiation.
Case presentation
A 69-year-old woman was referred to our hospital for
an operation concerning umbilical hernia who had been
diagnosed with hypertension and polycystic kidney dis-
ease one year prior to her surgery. Subsequent trans-
thoracic cardiac ultrasonography in our hospital showed
a club-shaped tumor of 34 mm in diameter inside the
left atrial cavity in a four-cavities tomogram. Transeso-
phageal cardiac ultrasonography showed a broad-based,
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entire left atrium (Figure 1). Chest computed tomogra-
phy (CT) showed no abnormality in the lungs or hilar
lymph nodes. Abdominal CT showed multilocular cysts
in bilateral kidneys. Cardiac magnetic resonance imaging
showed a broad-based protuberant tumor which had a
T1 iso-signal intensity and high T2 signal intensity in
the posterior wall of the left atrium. Positron emission
tomography analysis showed abnormal 18F- fluorodeoxy
glucose uptake which was detected only in the heart,
with the exception of the umbilical hernia lesion. These
results indicated the presence of primary cardiac malig-
nant tumor due to its atypical shape. Finally, surgical
removal with the patient’sp e r m i s s i o nw a sp e r f o r m e d .
Almost all of the tumor could be removed and subse-
quent chemotherapy was considered. However, the
patient’s renal dysfunction ruined adjuvant chemother-
apy and she died of her disease nine months after the
surgical removal due to multiple lung metastases.
Pathologic findings
Macroscopically, the submitted specimen comprised sev-
eral cakes of the tumor with a gray-white color on the
surface (Figure 2). It was fixed with 10% buffered forma-
lin, embedded in paraffin wax after dehydration, and cut
into four μm-thick sections. These were then prepared
and stained with hematoxylin and eosin (HE) double
stain for light microscopic observation.
Histopathologically, tumor cells that had proliferated
in the myxoedematous matrix (Figure 3A) consisted of
two different types: a large portion comprised spindle
cells, and polyhedral cells were also identified as a
minor component. Spindle cells had an elongated,
blunt-ended and hyperchromatic nucleus plus spindle,
were fibrillated and possessed an eosinophilic cytoplasm
(Figure 3D and 4A). In contrast, polyhedral cells had a
hyperchromatic and eccentric nucleus with a polyhedral,
large, and eosinophilic cytoplasm (Figure 5A). Spindle
cells showed twelve mitoses per ten high-power fields.
Accordingly, the histological grade of the tumor corre-
sponded to grade-2 (tumor differentiation: score-2;
mitotic counts: score-2; tumor necrosis: score-1) follow-
ing to the French National Federation of Cancer Centers
(FNCLCC) grading system (Figure 3C and 3D) [12].
Although a few polyhedral cells were confirmed, mor-
phological findings on HE double stain indicated a myx-
oid type of leiomyosarcoma.
Immunohistochemical findings
Several kinds of monoclonal antibody were used to eval-
uate tumor cells immunohistochemically and included
anti-Vimentin, CD31, CD34, cytokeratin (CK AE1/AE3,
34 b-E 12, 5/6, and CAM 5.2), desmin, a-smooth mus-
cle actin (a-SMA), myoglobin, myogenin, and Ki-67
(MIB-1) antibodies. All tumor cells showed strong posi-
tive reactivity for vimentin and negative reactivity for
CD31, CD34, and myoglobin (Figure 4D and 5D). Spin-
dle cells showed focal positive reactivity for desmin,
a-SMA, and cytokeratin CAM 5.2 (Figure 4B, C, and
4F). In contrast, polyhedral cells showed positive reactiv-
ity for desmin, but negative reactivity for a-SMA and
cytokeratin CAM 5.2 (Figure 5B, C, and 5F). Ki-67
(MIB-1) labeling index in the spindle and polyhedral
cells were estimated as 27.1% and 33.3%, respectively. It
is interesting to note that 2.1% of spindle cells and
23.1% of polyhedral cells showed positive reactivity for
myogenin (Figure 4E and 5E). Furthermore, to deter-
mine whether tumor cells are present as double positive
Figure 1 Photograph showing cardiac ultrasonography. (A) Transthoracic cardiac ultrasonography performed in our hospital showed
showing a club -shaped tumor of 34 mm in diameter inside the left atrial cavity in a four-cavities tomogram. (B) Transesophageal cardiac
ultrasonography showed showing a broad-based, gigantic, and multilocular tumor occupying almost the entire left atrium.
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Page 2 of 10for both a-SMA and myogenin, and to ascertain the
morphological characteristics of these tumor cells, we
performed double-immunostaining for a-SMA and
myogenin. The rates of a-SMA and myogenin double
negative, a-SMA single positive, myogenin single posi-
tive, and a-SMA and myogenin double positive in spin-
dle cells were estimated as 69.1%, 28.8%, 1.1%, and 1.0%,
respectively (Figure 6A, B, C, and 6D). In contrast, the
rates in polyhedral cells were estimated as 76.9%, 0.0%,
23.1%, and 0.0%, respectively. These results are summar-
ized in Table 1. According to the morphological and
immunohistochemical findings, we diagnosed this pri-
mary cardiac tumor as a leiomyosarcoma with partial
rhabdomyoblastic differentiation.
Figure 2 Photograph of the surgical specimen. The submitted specimen comprised several cakes of the tumor (measuring up to 41 × 28 ×
14 mm in size) with a gray-white color on the surface.
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Leiomyosarcoma occurring as a primary cardiac tumor
has been known as an extremely rare condition of which
the rate represents less than 1% of all primary cardiac
malignant tumors [2]. Furthermore, to the best of our
knowledge there has been no report of a case of primary
cardiac leiomyosarcoma with partial rhabdomyoblastic
differentiation. In general, leiomyosarcoma is currently
subdivided histologically into four types: classical, epithe-
lioid, pleomorphic, and myxoid [13]. The morphological
f i n d i n g so ft h ep r e s e n tc a s ei n d i c a t e dam y x o i dt y p eo f
leiomyosarcoma, but immunohistochemistry revealed
that a few tumor cells showed positive reactivity for myo-
genin. This has been known as a myogenic transcrip-
tional regulatory protein which is expressed in the early
phase of skeletal muscle differentiation (rhabdomyogenic
differentiation), and it induces differentiation of myo-
blasts into the multinucleated myotube [14]. This myo-
genic regulatory protein has been largely accepted as a
sensitive and specific immunohistochemical marker for
rhabdomyosarcoma or other tumors with rhabdomyo-
blastic differentiation [14].
Meanwhile, it is interesting to note that the spindle cell
showed positive reactivity for CK CAM 5.2. Although, it
has been well known that leiomyosarcoma usually
showed negative reactivity for epithelial markers [15],
some investigators described that a part of leiomyosar-
coma shows positive reactivity for CK [15-17]. Therefore,
CK CAM 5.2 expression in the present case may support
a diagnosis of leiomyosarcoma. However, to make diag-
nosis of leiomyosarcoma with rhabdomyoblastic differen-
tiation, we should refer three important tumors and deny
Figure 3 Photomicrographs showing spindle cells with areas of hypercellularity or necrosis. (A) Low-power view of the area with spindle
cells proliferation (Hematoxylin and Eosin (HE) double stain, × 40). (B) Spindle cells with positive reactivity for a-smooth muscle actin (SMA)
comprise approximately 30% area of the tumor (Immunostain, anti-a-SMA × 40). (C) There is focus of necrosis in the limited the tumor.
Following to the French National Federation of Cancer grading system, presence of tumor necrosis less than half in area corresponds to score-1
(HE double stain, × 100). (D) Spindle cells showed mitosis. On average, twelve mitoses per ten high-power fields were confirmed. Following to
the French National Federation of Cancer grading system, mitotic activity of the present case corresponds to score-2 (HE double stain, × 1000).
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morphic sarcoma (UPS), rhabdomyosarcoma, and rhab-
domyoma. Cardiac UPS usually occurring at the left
atrium, histopathologically comprises a mixture of spin-
dle cells in a storiform pattern with polyhedral cells [5].
Furthermore, high-grade undifferentiated sarcomas can
exhibit focal a-SMA expression [15]. These findings are
similar to the present case. However, the spindle cell, a
major component of the present tumor, had an elon-
gated, blunt-ended, and hyperchromatic nucleus plus
Figure 4 Photomicrographs showing spindle cells and their phenotypical expression. (A) Spindle cells had an elongated, blunt-ended and
hyperchromatic nucleus plus spindle, were fibrillated, and possessed an eosinophilic cytoplasm. Occasional cells have perinuclear vacuoles
(Hematoxylin and Eosin double stain, × 400). (B, C, D, E, and F) Photomicrographs of immunostain with desmin (B), a-smooth muscle actin (C),
myoglobin (D), myogenin (E), and cytokeratin CAM 5.2 (F), respectively (× 400).
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tion, the cell showed positive reactivity both for a-SMA
and desmin, focally, by immunohistochemical examina-
tion. These findings allowed disclosing the smooth mus-
cle differentiation. Furthermore, some of the spindle cell
also showed positive reactivity for CK CAM 5.2, of which
positive ratio has been reported ranging from 22.2% (2/9)
to 35.0% (14/40) in leiomyosarcoma [16,17]. Although it
still remains a difficulty for decision, we made the diag-
nosis of leiomyosarcoma rather than UPS. On the other
Figure 5 Photomicrographs showing polyhedral cells and their phenotypical expression. (A) Polyhedral cells had a hyperchromatic and
eccentric nucleus with a polyhedral, large, and eosinophilic cytoplasm (Hematoxylin and Eosin double stain, × 1000). (B, C, D, E, and F)
Photomicrographs of immunostain with desmin (B), a-smooth muscle actin (C), myoglobin (D), myogenin (E), and cytokeratin CAM 5.2 (F),
respectively (× 1,000).
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second most common primary cardiac malignant tumor
[2], that should also be considered as a disease for differ-
ential diagnosis. Especially, embryonal rhabdomyosar-
coma usually shows similar morphologic findings of the
present case, such as varying degrees of cellularity con-
taining hypercellular and loosely textured myxoid areas,
hyperchromatic and round or spindle-shaped nucleus,
and eosinophilic cytoplasm [18]. However, embryonal
rhabdomyosarcoma is uncommon in patients older than
40 years of age [18] and neither cross-striation nor myo-
g l o b i ne x p r e s s i o nw a sp r o v e ni nt h ep r e s e n tc a s e .
Furthermore, a large body of spindle cells showed nega-
tive reactivity for myogenin (only 2.1% of them showed
positive reactivity) that has been largely accepted as a
sensitive and specific immunohistochemical marker for
rhabdomyosarcoma or other tumors with rhabdomyo-
blastic differentiation [14]. According to our immunohis-
t o c h e m i c a le x a m i n a t i o n s ,w ew e r ea b l et od e n yt y p i c a l
rhabdomyosarcoma. As for rhabdomyoma, the most
common subtype of cardiac origin has been known as
cardiac rhabdomyoma, but it occurs almost exclusively in
the hearts of infants and young children and composes
predominantly large polygonal vacuolated spider cells
[19]. Therefore, the adult type of rhabdomyoma should
Figure 6 Photomicrograph showing the results of double-immunostaining of spindle cells. Positive reactivity for a-smooth muscle actin
(SMA) is recognized as a blue immunohistochemical signal in the cytoplasm, and for myogenin is recognized as a red immunohistochemical
signal in the nucleus. (A) Negative reactivity for both a-SMA and myogenin (× 1000). (B) Positive reactivity for a-SMA alone (× 1000). (C) Positive
reactivity for myogenin alone (× 1000). (D) Positive reactivity for both a-SMA and myogenin (× 1000).
Table 1 Summary of phenotypical expression by
immunohistochemical examination
Spindle cell Polyhedral cell
a-SMA and myogenin double negative
a-SMA (-) and myogenin (-)
69.1% 76.9%
a-SMA single positive
a-SMA (+) and myogenin (-)
28.8% 0.0%
myogenin single positive
a-SMA (-) and myogenin (+)
1.1% 23.1%
a-SMA and myogenin double positive
a-SMA (+) and myogenin (+)
1.0% 0.0%
SMA: smooth muscle actin.
The rates of a-SMA and myogenin double negative, a-SMA single positive,
myogenin single positive, and a-SMA and myogenin double positive in
spindle cells were estimated as 69.1%, 28.8%, 1.1% and 1.0%, respectively.
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composed of tightly polygonal cells which had peripher-
ally placed nucleus plus acidophilic, finely granular, and
vacuolated cytoplasm. However, mitotic figures are nearly
absent, cross-striations can be discerned, and show posi-
tive reactivity for rhabdomyogenic markers immunohis-
tochemically in these two subtypes of rhabdomyoma
[19]. These results were different from the findings
extracted from the present case.
On the other hand, only one case of sarcoma arisen
from myocardium with rhabdomyoblastic differentia-
tion has been reported by Kabir et al. [20] who
described a malignant peripheral nerve sheath tumor
indicated an area of rhabdomyoblastic differentiation
in part. In their report, a little information of immuno-
histochemical examinations was described which sim-
ply comprised positive reactivity for s-100 protein and
focal for desmin. These results were different from
these of the present case, but comparative discussion
could not be completed in detail. Therefore, we pre-
ferred to diagnose this primary cardiac malignant
tumor as a leiomyosarcoma with partial rhabdomyo-
blastic differentiation. Previous studies of leiomyosar-
coma with rhabdomyoblastic differentiation have
conducted to those arisen from another site, and
Oshiro et al. have reported that leiomyosarcoma with
rhabdomyoblastic differentiation shows poorer prog-
nosis than typical leiomyosarcoma [6]. In fact, the pre-
sent case showed rapid growth of the tumor and the
patient died due to extensive metastases in the lungs
despite early diagnosis and surgical removal. Table 2
presented herein summarizes major clinical data of
nineteen cases of leiomyosarcoma in soft tissue with
rhabdomyoblastic differentiation, and includes the pre-
sent case representing the first report of leiomyosar-
coma arising from the myocardium [table 2]. The
patient age ranged from 33 to 85 (mean: 62.7). The
male-to-female ratio was 10:10. The tumor sizes ran-
ged from 20 to 250 mm (mean: 116.4).
We wish to take a more detailed discussion on the
present case, especially in relation to tumor cell differen-
tiation with phenotypical expression analysis. The
Table 2 Literature summary of cases of leiomyosarcoma with rhabdomyoblastic differentiation
Reference Year Age
(years)
Sex Site Size
(mm)
Operation and adjuvant therapy Follow up
Falconieri et al [3]. 1996 83 Female Breast 60 Radical mastectomy 10 mo NED
Roncaroli et al [4]. 1996 59 Female Retroperitoneum 170 Excision 8 mo NED
Leoong et al [5]. 1996 56 Male Stomach 60 Partial gastrectomy NR
Oshiro et al [6]. 2000 55 Female Abdominal
cavity
180 Marginal excision 85 mo NED
Oshiro et al [6]. 2000 62 Female Omentum 130 Marginal excision NR
Oshiro et al [6]. 2000 53 Female Thigh, subcutis 80 Wide excision 19 mo DOD
Oshiro et al [6]. 2000 76 Male Buttock, subcutis 60 Wide excision 27 mo NED
Oshiro et al [6]. 2000 33 Male Thigh muscle 60 Wide excision 45 mo DOD
Oshiro et al [6]. 2000 54 Male Thigh muscle 220 Wide excision and chemotherapy Lung metastasis, 9 mo DOD
Oshiro et al [6]. 2000 84 Male Buttock 30 Wide excision, radiation, and
chemotherapy
93mo NED
Oda et al [7]. 2001 50 Female Back NR Excision 6 mo DOD
Oda et al [7]. 2001 60 Male Retroperitoneum 140 Excision NR
Oda et al [7]. 2001 85 Male Buttock 20 Excision 5 mo local recurrence (additional
wide excision), 65 mo NED
Oda et al [7]. 2001 33 Male Thigh 60 Wide excision and chemotherapy Lung metastasis, 45 mo DOD
Oda et al [7]. 2001 76 Male Buttock 60 Excision NR
Levine et al [8]. 2002 72 Female Uterus 210 Hysterectomy with salpingo-
oophorectomy
6 mo NED
Shintaku et al [9]. 2004 70 Female Uterus 250 Hysterectomy with salpingo-
oophorectomy and chemotherapy
Liver metastasis, outcome was NR
Nikaido et al [10]. 2004 67 Male Inferior vena
cava
140 Radical excision Lung metastasis, 13 mo DOD
Yorulmaz et al [11]. 2007 56 Female Uterus 240 Surgical removal, radiation, and
chemotherapy
8 mo DOD
Present case 2009 69 Female Heart 41 Surgical removal Lung metastasis, 9 mo DOD
NR: not reported, DOD: died of disease, NED: no evidence of disease, mo: months.
There are twenty cases of leiomyosarcoma with rhabdoid differentiation including the present case.
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potential to differentiate into a smooth muscle cell
which can be phenotypically identified with positive
reactivity for a-SMA. However, we found 2.1% of
spindle cells showed positive reactivity for myogenin,
and half of myogenin-positive spindle cells showed
positive reactivity for a-SMA at the same time. In con-
trast, none of polyhedral cells showed positive reactiv-
ity for a-SMA, but they exhibited a significantly higher
myogenin-positive rate than spindle cells. These find-
ings support the following hypothesis. First, the “rhab-
domyoblastic differentiation” observed in the present
case may represent the early stage of rhabdomyogenic
differentiation because tumor cells showed positive
reactivity for myogenin which has been known as a
maker of cells in the early phase of rhabdomyogenic
differentiation, and exhibited neither cross-striation
nor myoglobin expression. Second, polyhedral cells
may be in a more advanced stage of rhabdomyogenic
differentiation than spindle cells because polyhedral
cells were morphologically similar to rhabdomyoblasts
a n ds h o w e das i g n i f i c a n t l yh igher myogenin-positive
rate than spindle cells.
Finally, the possibility of transdifferentiation or syn-
chronous smooth and skeletal muscle differentiation in
leiomyosarcoma was suggested in the present case
because synchronous expression of a-SMA and myo-
genin was confirmed in 1.0% of spindle cells. Overall,
our immunohistochemical evaluation indicated that
rhabdomyoblastic differentiation in leiomyosarcoma
might be generated not only by de novo generation
from mesenchymal cells.
Conclusion
We describe an extremely rare case of primary cardiac
leiomyosarcoma with partial rhabdomyoblastic differen-
tiation. The tumor indicated aggressive growth and the
patient died despite early diagnosis and surgical removal.
Furthermore, our immunohistochemical evaluation
suggested that rhabdomyoblastic differentiation in
leiomyosarcoma might be generated not only by de
novo generation from mesenchymal cells. To the best of
our knowledge, this is the first report of primary cardiac
leiomyosarcoma with partial rhabdomyoblastic
differentiation.
Consent
We could not get the proof of the patient’s written and
signed consent for the publication because we could not
announce disease of our patient to herself due to her
family’s request. Furthermore, the patient has already
died. However her family agreed our proposal using sur-
gical specimen for our research and written informed
consent was obtained from the patient’s family (as a
proxy) for publication of this case report and any
accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this
journal.
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